NVR Gears Up to Report Q4 Earnings: What's in the Cards?
https://www.zacks.com/stock/news/2215086/nvr-gears-up-to-report-q4-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2215086
Jan 24, 2024 - NVR's fourth-quarter 2023 results are quite likely to reflect high mortgage rates and reduced new homes settlements.
0
College enrollment picks up for the first time in over a decade — but student loan debt is still a major sticking point
https://www.cnbc.com/2024/01/24/college-enrollment-picks-up-but-student-loan-debt-is-still-a-sticking-point.html
Jan 24, 2024 - More students went to college this fall, but there's been a shift toward shorter-term programs over four-year degrees.
0
Don’t let this passport quirk upend your next vacation. It 'trips a lot of people up,' expert says
https://www.cnbc.com/2024/01/23/dont-let-this-passport-quirk-upend-your-next-vacation.html
Jan 23, 2024 - Depending on the destination, your passport may need to be valid for at least six more months in order to board the airplane.
0
Inhibrx (INBX) Up 6% on Sale of Rare Disease Drug to Sanofi
https://www.zacks.com/stock/news/2214518/inhibrx-inbx-up-6-on-sale-of-rare-disease-drug-to-sanofi?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2214518
Jan 23, 2024 - Sanofi (SNY) will acquire Inhibrx (INBX) for nearly $2.2 billion. Post-acquisition, it will retain the rare disease drug and spin out all other pipeline programs into a newly-traded public company.
0
Hilton (HLT) Reports Solid 2023 Unit Growth, Signings Up Y/Y
https://www.zacks.com/stock/news/2214454/hilton-hlt-reports-solid-2023-unit-growth-signings-up-y-y?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2214454
Jan 23, 2024 - Hilton (HLT) anticipates a favorable trajectory in 2024 net unit growth, backed by robust signings and construction starts. Also, the addition of Spark by Hilton and LivSmart Studios bodes well.
0
Gartner (IT) Is Up 2.35% in One Week: What You Should Know
https://www.zacks.com/stock/news/2214410/gartner-it-is-up-2-35-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2214410
Jan 23, 2024 - Does Gartner (IT) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
Salesforce.com (CRM) Is Up 3.29% in One Week: What You Should Know
https://www.zacks.com/stock/news/2214414/salesforce-com-crm-is-up-3-29-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2214414
Jan 23, 2024 - Does Salesforce.com (CRM) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
Gear Up for Gentex (GNTX) Q4 Earnings: Wall Street Estimates for Key Metrics
https://www.zacks.com/stock/news/2214384/gear-up-for-gentex-gntx-q4-earnings-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2214384
Jan 23, 2024 - Get a deeper insight into the potential performance of Gentex (GNTX) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
0
Samsung, Apple race to shake up glucose monitoring market: Bloomberg
https://seekingalpha.com/news/4057426-samsung-apple-race-shake-up-glucose-monitoring-market?source=feed_sector_healthcare
Jan 23, 2024 - Samsung(SSNLF) is developing blood glucose monitoring technology to compete with Apple (AAPL) in a market dominated by the likes of Medtronic (MDT). Read more here.
0
UPS Gears Up to Release Q4 Earnings: What's in the Offing?
https://www.zacks.com/stock/news/2214343/ups-gears-up-to-release-q4-earnings-what-s-in-the-offing?cid=CS-ZC-FT-analyst_blog|earnings_preview-2214343
Jan 23, 2024 - UPS fourth-quarter 2023 results are likely to gain from falling expenses.
0